Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. Fecha: Viernes 28 de diciembre de 2018
Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives. Authors: Marone G1,2, Galdiero MR3,4, Pecoraro A3,4, Pucino V5, Criscuolo G3,4, Triassi M1, Varricchi G3,4. 1 a Department of Public Health , University of Naples Federico II , Naples , Italy. 2 b Monaldi Hospital Pharmacy , Naples , Italy. 3 c Department of Translational Medical Sciences and Center for Basic and Clinical Immunology Research (CISI) , University of Naples Federico II , Naples , Italy. 4 d WAO Center of Excellence , Naples , Italy. 5 e William Harvey Research Institute, Barts and The London School of Medicine &Dentistry , Queen Mary University of London , London , UK. Abstract: Prostaglandin D2 (PGD2) is a major cyclooxygenase mediator that is synthesized by activated human mast cells and other immune cells. The biological effects of PGD2 are mediated by D-prostanoid (DP1), DP2 (CRTH2) and thromboxane prostanoid (TP) receptors that are expressed on s...